Home - News - Company News Company News
Pompe Patient Guoguo Received A Second Myoblast Transplant

On October 28, 2015, Guoguo received the first myoblasts transplantation treatment for childhood Pompe disease. The heart and lung functions of Guoguo showed improvement half- a -year post-operatively. The strength of the head and neck, limbs and waist was significantly enhanced.(Previous efficacy video link: http://v.youku.com/v_show/id_XMTgyOTc1NzIxMg==.html?from=s1.8-1-1.2&spm=a2h0k.8191407.0.0.Up to now, she has been more than 3 years old. In addition to having her lifespan extended over the 2- year limit, she is now able to stand under the protection of the auxiliary stand.

In order to further strengthen her muscle strength and cardiopulmonary function, and to promote normal development. Guoguo received a second myoblast transplant in Henan (Zhengzhou) Children's Hospital on September 22, 2017, which cooperated with our institute in the clinical trial of children with hereditary, rare diseases.

 The above image shows Guoguo receiving preoperative massage stimulation.